A Prospective, International, Multi-centre, Open-label, Single-arm Phase II Study Investigating the Predictive Value of [68Ga]Ga PentixaFor PET Imaging in Primary and Isolated Secondary CNS Lymphoma Patients
Latest Information Update: 31 Oct 2023
At a glance
- Drugs 68Ga PentixaFor (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Diagnostic use
- Sponsors PentixaPharm
- 08 May 2023 Status changed from recruiting to discontinued.
- 24 Oct 2022 Status changed from not yet recruiting to recruiting.
- 19 Apr 2022 Planned initiation date changed from 1 Mar 2022 to 1 Jun 2022.